Skip to main content

Heartbeam Inc (BEAT) Stock

Heartbeam Inc Stock Details, Movements and Public Alerts

Stock Details

Heartbeam Inc (BEAT), a prominent company in the healthcare sector within the health information services industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $2.30. Over the past 52 weeks, it has ranged between $0.54 and $3.48. This places the current price at 66.1% of its 52-week high and 325.9% above its 52-week low. Recent trading volume was recorded at 64,249,132. The 14-day Relative Strength Index (RSI) stands at 74.93, suggesting overbought conditions. The stock is currently trading above its 50-day moving average of $1.47 by 56.46%. Similarly, it is above its 200-day moving average of $1.53 by 50.33%. The MACD histogram is 0.18, indicating bullish momentum (MACD Line: 0.04, Signal Line: -0.14). There is currently 1 active alert set for BEAT by users.

52-Week Range

$3.48 - $0.54

-33.91% from high · +325.93% from low

Avg Daily Volume

31,457,118

20-day average

100-day avg: 6,369,111

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

195.12

EV/EBITDA

-3.00

EPS (TTM)

-$0.66

Beta

-0.58

Less volatile than market

How is BEAT valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is BEAT's risk profile compared to the market?
With a beta of -0.58, Heartbeam Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 195.12 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-19,880,000

Return on Equity

-792.00%

Return on Assets

-272.40%

Revenue Growth (YoY)

0.00%

Earnings Growth (YoY)

0.00%

How profitable and efficient is BEAT's business model?
Profitability metrics are not available for this stock.
What are BEAT's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$79.2M

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

34.44M

Book Value/Share

$0.01

Asset Type

Common Stock

What is BEAT's market capitalization and position?
Heartbeam Inc has a market capitalization of $79.2M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 34.44M shares outstanding, the company's ownership is relatively concentrated. As a participant in the HEALTH INFORMATION SERVICES industry, it competes with other firms in this sector.
How does BEAT's price compare to its book value?
Heartbeam Inc's book value per share is $0.01, while the current stock price is $2.30, resulting in a price-to-book (P/B) ratio of 191.67. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$4.63

101.09% upside potential

Analyst Recommendations

Strong Buy

1

Buy

1

Hold

1

Sell

0

Strong Sell

0

How reliable are analyst predictions for BEAT?
3 analysts cover BEAT with 67% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $4.63 implies 101.1% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on BEAT?
Current analyst recommendations:1 Strong Buy, 1 Buy, 1 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Dec 14, 2025, 02:07 AM

Technical Indicators

RSI (14-day)

74.93

Overbought

50-Day Moving Average

$1.47

56.46% above MA-50

200-Day Moving Average

$1.53

50.33% above MA-200

MACD Line

0.04

MACD Signal

-0.14

MACD Histogram

0.18

Bullish

What does BEAT's RSI value tell investors?
The RSI (Relative Strength Index) for BEAT is currently 74.93, indicating the stock is in overbought territory (above 70). This suggests strong recent buying pressure that may be unsustainable. While overbought conditions can persist in strong trends, traders often watch for RSI divergences or a drop below 70 as potential sell signals. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret BEAT's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.04 above the signal line at -0.14, with histogram at 0.18. This bullish crossover suggests upward momentum is building. The 50-day MA ($1.47) is below the 200-day MA ($1.53), forming a death cross pattern that often warns of extended weakness. Price is currently above both MAs, confirming strength.

Indicators last updated: Dec 14, 2025, 12:43 AM

Active Alerts

Alert Condition
Price falls below
Threshold
$1.90
Created
Dec 11, 2025, 04:58 PM

Stay Ahead of the Market with Heartbeam Inc Alerts

Set up price alerts for Heartbeam Inc and get notified instantly when the price hits your target. Never miss an important price movement again.